Immune response to anti-SARS-CoV-2 prime-vaccination in patients with cancer: a systematic review and meta-analysis.

Diogo Martins-Branco Guilherme Nader Marta Ana Tečić Vuger Veronique Debien Lieveke Ameye Mariana Brandão Kevin Punie Angela Loizidou Karen Willard-Gallo Chloe Spilleboudt Ahmad Awada Martine J Piccart Evandro de Azambuja

Published in: Journal of cancer research and clinical oncology (2022)

This meta-analysis provides compelling evidence of humoral and adaptive immune responses against SARS-CoV-2 in patients with cancer, which last for at least 2 months following complete prime-vaccination.

Keyphrases

immune response
sars cov
systematic review
respiratory syndrome coronavirus
dendritic cells
toll like receptor
meta analyses
randomized controlled trial
coronavirus disease